Scancell to produce and clinically validate T cell redirecting bispecific antibodies, a promising new therapeutic to treat cancer.
Over 20 years investing in innovative UK companies
Calculus Capital is a pioneer of tax efficient investing, having launched the UK’s first approved EIS Fund in 1999. We offer an opportunity to invest in a portfolio of entrepreneurial UK growth businesses, through our award winning Calculus EIS Fund and Calculus VCT. We invest in the fastest growing sectors of the UK economy – technology, healthcare and creative industries.
Looking to invest?
Learn about the tax-efficient investment opportunities offered by our Calculus EIS Fund and Calculus VCT
We would be delighted to learn about your business and discuss whether Calculus could be a suitable investment partner
Calculus Capital closed three deals in three days across the Calculus VCT and EIS Funds
Calculus has completed an investment into Riff Raff Entertainment, the production company headed up by Jude Law and Ben Jackson
This latest round is to enable smart scheduling company to meet growing client demand